Fraction genome altered outperforms tumor mutational burden for machine learning-based mortality prediction across TP53, PIK3CA, GATA3, and MAP3K1 subtypes in invasive ductal carcinoma
- 6 November 2026
- journal article
- research article
- Published by Springer Nature in Wiener Medizinische Wochenschrift
- p. 1-8
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- CLABpredICU---AI-driven risk prediction for CLABSI in intensive care units based on clinical and biochemical parametersAmerican Journal of Infection Control, 2025
- Automated real-world data integration improves cancer outcome predictionNature, 2024
- Molecular profiling of a bladder cancer with very high tumour mutational burdenCell Death Discovery, 2024
- Tumor mutational burden and somatic mutation status to predict disease recurrence in advanced melanomaMelanoma Research, 2022
- Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid TumorsJAMA Network Open, 2020
- Chromosome Abnormalities: New Insights into Their Clinical Significance in CancerMolecular Therapy-Oncolytics, 2020
- High Levels of Chromosomal Copy Number Alterations and TP53 Mutations Correlate with Poor Outcome in Younger Breast Cancer PatientsThe American Journal of Pathology, 2020
- Mechanisms of Genomic Instability in Breast CancerTrends in Molecular Medicine, 2019
- Molecular Subtypes and Local-Regional Control of Breast CancerSurgical Oncology Clinics of North America, 2018
- Genomic instability and poor prognosis associated with abnormal TP53 in breast carcinomas. Molecular and immunohistochemical analysisAPMIS, 1997